All In Biotech

Drug Trial Radar · NCT03000348

A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease

Last checked: Nov 19, 2026Latest source record: Apr 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

91

Actual

Start

Dec 2016

Primary completion

Apr 2018

Study completion Apr 2018

Sponsor

Lead sponsor
NovaBiotics Ltd.Industry
Sponsor type
Industry
Collaborators
Agility Clinical, Inc.; PSR Group B.V.
First posted
Dec 22, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study investigates the use of cysteamine in the treatment of adults with Cystic Fibrosis who are experiencing an exacerbation of CF-associated lung disease. There are six different potential dosing regimens, including one that is placebo.

Conditions

  • Cystic Fibrosis

Interventions

  • CysteamineDrug

    Oral Cysteamine Capsule

  • Placebo Oral CapsuleDrug

    Placebo Oral Capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Sputum Bacterial LoadTime frame: Baseline through Day 21/End of Study
  2. Safety and Tolerability Assessed by the Number of Subjects With Adverse EventsTime frame: Baseline through Day 21/End of Study

Locations

17 sites in 3 countries. Site status is shown where the registry gives one.

  • Banner University of Arizona Medical Center

    Tucson, Arizona

  • San Francisco Critical Care Medical Group California Pacific Medical Center

    San Francisco, California

  • University of Florida

    Gainesville, Florida

  • Central Florida Pulmonary

    Orlando, Florida

  • Albany Medical College

    Albany, New York

  • Nationwide Children's Hospital

    Columbus, Ohio

  • West Virginia University

    Morgantown, West Virginia

  • The Medical College of Wisconsin/Froedtert Hospital

    Milwaukee, Wisconsin

  • Ospedale Padiatrico Bambino Gesu Centro Fibrosi Cistica

    Roma, Italy

  • Azienda Ospedaliera Universitaria Integrato di Verona Borgo Trento Centro Fibrosi Cistica

    Verona, Italy

  • Ninewells Hospital Scottish Adult Cystic Fibrosis Service

    Dundee, United Kingdom

  • Western General Hospital Edinburgh, CF Adults / CF Unit

    Edinburgh, United Kingdom

  • NHS GGC

    Glasgow, United Kingdom

  • Raigmore Hospital

    Inverness, United Kingdom

  • St. James University Hospital

    Leeds, United Kingdom

  • Royal Victoria Infirmary Adult CF Centre

    Newcastle upon Tyne, United Kingdom

  • Aberdeen Royal Infirmary

    Aberdeen, Scotland, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.